Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 125
2021 248
2022 215
Text availability
Article attribute
Article type
Publication date

Search Results

536 results
Use COVID-19 filters from PubMed Clinical Queries to refine your search See more SARS-CoV-2 literature, sequence, and clinical content from NCBI
Results by year
Filters applied: . Clear all
Page 1
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines.
Bryant A, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Bryant A, et al. Am J Ther. 2021 Jun 21;28(4):e434-e460. doi: 10.1097/MJT.0000000000001402. Am J Ther. 2021. PMID: 34145166 Free PMC article.
BACKGROUND: Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials. ...The apparent safety and low cost suggest t …
BACKGROUND: Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, wit …
Ivermectin in COVID-19: What do we know?
Pandey S, Pathak SK, Pandey A, Salunke AA, Chawla J, Sharma A, Sharma S, Thivari P, Ratna HVK. Pandey S, et al. Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1921-1922. doi: 10.1016/j.dsx.2020.09.027. Epub 2020 Sep 28. Diabetes Metab Syndr. 2020. PMID: 33032231 Free PMC article. Review. No abstract available.
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness.
Ahmed S, Karim MM, Ross AG, Hossain MS, Clemens JD, Sumiya MK, Phru CS, Rahman M, Zaman K, Somani J, Yasmin R, Hasnat MA, Kabir A, Aziz AB, Khan WA. Ahmed S, et al. Int J Infect Dis. 2021 Feb;103:214-216. doi: 10.1016/j.ijid.2020.11.191. Epub 2020 Dec 2. Int J Infect Dis. 2021. PMID: 33278625 Free PMC article. Clinical Trial.
Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro. ...There were no severe adverse drug events recorded in the stud …
Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome c …
Ivermectin for preventing and treating COVID-19.
Popp M, Stegemann M, Metzendorf MI, Gould S, Kranke P, Meybohm P, Skoetz N, Weibel S. Popp M, et al. Cochrane Database Syst Rev. 2021 Jul 28;7(7):CD015017. doi: 10.1002/14651858.CD015017.pub2. Cochrane Database Syst Rev. 2021. PMID: 34318930 Free PMC article. Updated.
The molecular hypothesis of ivermectin's antiviral mode of action suggests an inhibitory effect on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in the early stages of infection. Currently, evidence on efficacy …
The molecular hypothesis of ivermectin's antiviral mode of action suggests an inhibitory effect on severe acute respiratory sy …
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial.
López-Medina E, López P, Hurtado IC, Dávalos DM, Ramirez O, Martínez E, Díazgranados JA, Oñate JM, Chavarriaga H, Herrera S, Parra B, Libreros G, Jaramillo R, Avendaño AC, Toro DF, Torres M, Lesmes MC, Rios CA, Caicedo I. López-Medina E, et al. JAMA. 2021 Apr 13;325(14):1426-1435. doi: 10.1001/jama.2021.3071. JAMA. 2021. PMID: 33662102 Free PMC article. Clinical Trial.
IMPORTANCE: Ivermectin is widely prescribed as a potential treatment for COVID-19 despite uncertainty about its clinical benefit. ...The findings do not support the use of ivermectin for treatment of mild COVID-19, although larger trials …
IMPORTANCE: Ivermectin is widely prescribed as a potential treatment for COVID-19 despite uncertainty about its clinica …
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen.
Heidary F, Gharebaghi R. Heidary F, et al. J Antibiot (Tokyo). 2020 Sep;73(9):593-602. doi: 10.1038/s41429-020-0336-z. Epub 2020 Jun 12. J Antibiot (Tokyo). 2020. PMID: 32533071 Free PMC article.
Furthermore, there are some studies showing antiviral effects of ivermectin against DNA viruses such as Equine herpes type 1, BK polyomavirus, pseudorabies, porcine circovirus 2, and bovine herpesvirus 1. Ivermectin plays a role in several biological mechanis …
Furthermore, there are some studies showing antiviral effects of ivermectin against DNA viruses such as Equine herpes type 1, BK poly …
Ivermectin for Prophylaxis and Treatment of COVID-19: A Systematic Review and Meta-Analysis.
Cruciani M, Pati I, Masiello F, Malena M, Pupella S, De Angelis V. Cruciani M, et al. Diagnostics (Basel). 2021 Sep 8;11(9):1645. doi: 10.3390/diagnostics11091645. Diagnostics (Basel). 2021. PMID: 34573986 Free PMC article. Review.
BACKGROUND: Ivermectin has received particular attention as a potential treatment for COVID-19. ...Further evidence is needed to fine-tune potential indications and optimal treatment protocols for ivermectin as a treatment for COVID-19... …
BACKGROUND: Ivermectin has received particular attention as a potential treatment for COVID-19. ...Further evidence is …
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19.
Sharun K, Dhama K, Patel SK, Pathak M, Tiwari R, Singh BR, Sah R, Bonilla-Aldana DK, Rodriguez-Morales AJ, Leblebicioglu H. Sharun K, et al. Ann Clin Microbiol Antimicrob. 2020 May 30;19(1):23. doi: 10.1186/s12941-020-00368-w. Ann Clin Microbiol Antimicrob. 2020. PMID: 32473642 Free PMC article. No abstract available.
Therapeutic potential of ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis.
Padhy BM, Mohanty RR, Das S, Meher BR. Padhy BM, et al. J Pharm Pharm Sci. 2020;23:462-469. doi: 10.18433/jpps31457. J Pharm Pharm Sci. 2020. PMID: 33227231 Free article.
The current management of COVID-19 is mostly limited to general supportive care and symptomatic treatment. ...Hence, we conducted this systematic review and meta-analysis to assess the currently available data on the therapeutic potential of ivermectin for th …
The current management of COVID-19 is mostly limited to general supportive care and symptomatic treatment. ...Hence, we conduc …
536 results

Searches related to "ivermectin covid"